Delivery Order SPE2DX15D6038-SPE2DX24F2BR2
Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $2.9K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,198.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 50 mg vials of the drug Activase. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,901.34 firm fixed-price contract is for the supply of 50 mg vials of the drug Activase. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Activase 100 mg vials. The contract has a firm fixed price of $17,103.37 and a completion date of September 6, 2024. Amerisourcebergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a $14,164.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 100 mg vials of the pharmaceutical product ACTIVASE. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the supply of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a potential value of $10,990.82 and a completion date of February 2, 2024. This delivery order is placed under Amerisourcebergen's indefinite delivery contract (IDC) with DLA, which has a potential...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 50 MG VIALS, a medical product, and has a firm fixed-price ceiling value of $9,014.34. The contract is non-set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order under a prime contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of 100 mg vials of the drug Activase, a critical medical product used in emergency care. The award has a ceiling value of $14,852.25 and a completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of ACTIVASE 100 MG VIALS. The contract has a ceiling value of $70,291.64 and a period of performance through August 6, 2024. The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide the requested medical product to support military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,927.44 fixed-price delivery order covers the supply of 50 mg vials of the drug Activase, with a completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 50 MG VIALS, a medical product, with a ceiling value of $11,871.88 and a performance period through May 20, 2025. The contract is a firm fixed-price delivery order, which is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant...